BioSpace News Archive

New medicine one of several limited distribution drugs available through specialty pharmacy

The meditation and sleep app, part of Kaiser Permanente’s self-care portfolio, supports people looking for ways to manage stress and build resilience, particularly in uncertain times.

Cart is customizable to different workflows to help caregivers attend to patients, not technology

Today, Florence announces its rapidly expanding clinical research sponsor and site connectivity platform is now in use at more than 7,200 research sites and by 18,000 research professionals across 27 countries – making it the largest established site and sponsor connectivity platform in research.

While individuals with osteoarthritis (OA) who undergo joint replacement surgery often experience reductions in pain, emotional distress and improved function, there is little known about how these recovery-related changes impact their spouse or marital relationship.

The American Urological Association announced the following new officers and members to its Board of Directors

Hoag Family Cancer Institute and Pickup Family Neurosciences Institute at Hoag, in collaboration with Nascent Biotech, Inc announced today a first in the nation clinical trial for a novel immunotherapy treatment that holds considerable promise for glioblastoma (GBM), the deadliest form of brain cancer.

The PA profession has grown by 37 percent in the past five years; 10,000 new Certified PAs added in 2019 alone

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announced funding for 14 new projects in technology, workforce development, and in their Global Health Fund initiative, resulting from the Institute’s Project Call 3.1, and with a total value of approximately $10M.

VolitionRx Limited, a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to help diagnose a range of cancers and other diseases, announced that it intends to offer and sell shares of its common stock in an underwritten public offering.